Pediatric Spinal Atypical Teratoid Rhabdoid Tumor: Recent Advances in Biology and Management Options

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Rare Cancers

Background:

• Atypical teratoid rhabdoid tumor (AT/RT) is a rare, aggressive embryonal central nervous system malignancy in infants and toddlers.
• Spinal AT/RT (spAT/RT) is exceptionally rare, limiting knowledge of prognostic factors and optimal treatments.
• AT/RTs are molecularly classified into AT/RT-SHH, AT/RT-TYR, and AT/RT-MYC subtypes, with spAT/RT predominantly being the MYC subtype.

Purpose of the Study:

• To review the published literature on spinal atypical teratoid rhabdoid tumors (spAT/RT).
• To emphasize recent advances in understanding spAT/RT biology and current therapeutic options.
• To highlight challenges in managing this rare condition.

Main Methods:

• Comprehensive literature review of published studies on spAT/RT.
• Analysis of molecular subtypes and their prevalence in spAT/RT.
• Examination of current treatment strategies and their outcomes.

Main Results:

• spAT/RT is predominantly of the MYC molecular subtype.
• A significant proportion of AT/RT patients have Rhabdoid Tumor Predisposition Syndrome (RTPS).
• There is a lack of consensus on optimal treatment strategies due to tumor rarity.

Conclusions:

• Understanding spAT/RT biology is crucial for developing targeted therapies.
• Multidisciplinary approaches are essential for managing spAT/RT.
• Further research is needed to establish standardized treatment protocols for spAT/RT.